Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status:
Enrolling by invitation
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
Multiple centers, uncontrolled, open-label, non-randomized single-arm study
Phase:
Phase 2
Details
Lead Sponsor:
National Health Research Institutes, Taiwan
Collaborators:
Chang Gung Memorial Hospital China Medical University Hospital Kaohsiung Medical University National Cheng-Kung University Hospital National Taiwan University Hospital